跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alunbrig - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Alunbrig
Approved
STANDARD
Alunbrig
Penn Pharmaceutical Services Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ff697bd4584821ca
Company
Penn Pharmaceutical Services Limited
Type
Standard
Approval Details
Approval Id
ff697bd4584821ca
Drug Approval Philippines Name
Alunbrig
Product Name
Alunbrig
Registration Number
DR-XY48474
Brand Name
Alunbrig
Generic Name
Brigatinib
Dosage Form
Film-Coated Tablet
Dosage Strength
180mg
Manufacturer
Penn Pharmaceutical Services Limited
Importer
Takeda Healthcare Philippines Inc.
Company Detail Path
/organization/penn-pharmaceutical-services-limited
Issuance Date
18 November 2022
Expiry Date
18 November 2027
Pharmacologic Category
Antineoplastic [Anaplastic Lymphoma Kinase (ALK) Inhibitor]
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ff697bd4584821ca
Type
Standard
Back to Philippines FDA Approvals